https://www.selleckchem.com/pr....oducts/abr-238901.ht
Bladder cancer care has been increasingly concentrated in high-volume metropolitan medical centres (ie, "regionalisation" of care). We aimed to assess the potential role of geographic factors, including facility region and distance to treatment centre, as determinants of neoadjuvant chemotherapy (NAC) delivery in patients with non-metastatic urothelial muscle-invasive bladder cancer (MIBC) using nationally representative data from the United States. We queried the National Cancer Database to identify patients with cT2-cT4a, N0M0 urot
Like
Comment
Share
